Skeletal muscle insulin resistance in endocrine disease. - Wikidata - awgldk - TriplyDB

Skeletal muscle insulin resistance in endocrine disease.

Skeletal muscle insulin resistance in endocrine disease.

http://www.wikidata.org/entity/Q33734293

about

Sunflower oil supplementation has proinflammatory effects and does not reverse insulin resistance in obesity induced by high-fat diet in C57BL/6 mice Novel Endogenous, Insulin-Stimulated Akt2 Protein Interaction Partners in L6 Myoblasts Association between Lower Normal Free Thyroxine Concentrations and Obesity Phenotype in Healthy Euthyroid Subjects Insulin resistance in hypothyroid patients under Levothyroxine therapy: a comparison between those with and without thyroid autoimmunity The zinc transporter, Slc39a7 (Zip7) is implicated in glycaemic control in skeletal muscle cells.Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.Identification of a conserved set of upregulated genes in mouse skeletal muscle hypertrophy and regrowth Why can insulin resistance be a natural consequence of thyroid dysfunction?Nutrigenomics and personalized diets: What will they mean for food?Co-activator binding protein PIMT mediates TNF-α induced insulin resistance in skeletal muscle via the transcriptional down-regulation of MEF2A and GLUT4.Maternal moderate physical training during pregnancy attenuates the effects of a low-protein diet on the impaired secretion of insulin in rats: potential role for compensation of insulin resistance and preventing gestational diabetes mellitus Molecular targets related to inflammation and insulin resistance and potential interventions Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus.Association between thyroid hormone levels and insulin resistance and body mass index Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism.Carotid Intima-Media Thickness as the Cardiometabolic Risk Indicator in Patients with Nonfunctional Adrenal Mass and Metabolic Syndrome Screening.Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism and hyperthyroidism Diagnostic criteria for sarcopenia relate differently to insulin resistance.Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications.Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.Endocrine factors in the hypothalamic regulation of food intake in females: a review of the physiological roles and interactions of ghrelin, leptin, thyroid hormones, oestrogen and insulin.The interface between thyroid and diabetes mellitus.Progressive resistance training in polycystic ovary syndrome: can pumping iron improve clinical outcomes?miR-378 attenuates muscle regeneration by delaying satellite cell activation and differentiation in mice.Anti-Diabetic Effect of Pectinase-Processed Ginseng Radix (GINST) in High Fat Diet-Fed ICR Mice.Variations of Adipokines and Insulin Resistance in Primary Hypothyroidism.Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3.Jiaotai Pill enhances insulin signaling through phosphatidylinositol 3-kinase pathway in skeletal muscle of diabetic rats.Zinc stimulates glucose oxidation and glycemic control by modulating the insulin signaling pathway in human and mouse skeletal muscle cell lines.IL-15 expression increased in response to treadmill running and inhibited endoplasmic reticulum stress in skeletal muscle in rats.Diagnostic measures for sarcopenia and bone mineral density

P2860

Q28388533-6EDB247B-3BE5-42B6-BF1E-FFB4B69CEC9D Q28550274-256AA63C-28C9-4ECA-9964-5E807A4F0603 Q33625162-B7F57841-9BD4-4286-8056-5F44A9026CAD Q34437948-D347B546-E662-4279-8446-7D9212D71615 Q35050466-2402D6F8-65AB-495B-8FDA-8F8B69455FB6 Q35116881-2BB5B48C-5178-4169-B43D-4F3F999AF63F Q35141339-3F56A2EC-AF3C-4EBA-A421-2FEF5173E36A Q35220185-76FBF2BF-B44C-49B8-8021-B9E43008D655 Q35551472-F4DE7F93-89DE-4185-BFF6-44E993B7E50B Q36163897-BA44017D-0E71-4207-901A-6E999BD56463 Q36184050-C2F4B2FA-D8BA-4B68-AF39-91F53248E860 Q36294297-DE808D93-F295-4BF2-954D-C8349C8F4BB2 Q36490385-D0F990DB-0C8B-4677-8A63-6891173D5EC7 Q36552924-D120516A-D5FB-4083-AC87-A187C4D27C88 Q36566934-4B25D755-BA84-4179-AA32-A731D4092094 Q36738268-B7D14653-008A-4128-B1DE-AA0E4DC8996D Q36816280-1BEDF6D2-1ACF-4B23-931B-101DA2F9436C Q36914776-7607F727-24E2-4DE2-9833-0CF5A56B73DB Q37300566-6A161DBE-BFB4-456B-B886-F2C25503152F Q37365514-BD16077F-D8D7-4918-ADB8-5EE4B1153055 Q37801979-84AD35BE-7F2C-403D-85A7-315518DC8B26 Q37830746-BB13F861-B0E6-4D58-8786-A65371C58906 Q37854918-5F5BD7FF-F043-4AF3-9CF6-5BA32D9F3F0E Q37869199-CD429341-08E1-4796-99E0-E1155D0BF279 Q38215719-39D8A156-E6C4-434B-A470-5FC320E312F4 Q38750010-8FF9CF90-CA82-4E25-9079-8D8372C5798B Q40877016-951DEABE-DD6F-49F0-BFD4-A1045DABA62A Q41893333-534775E9-3CFF-4EE0-85AE-A242F7D7BDB1 Q41986846-5AB2596D-5E08-4A64-8529-15430F741DA0 Q44510344-6127F447-51C2-4F2A-8AA4-1F72CEE88DF6 Q48159058-990EEA0F-56E4-4E3A-A2A5-E6D546A07257 Q51325348-043A6023-73BA-4213-9367-0F3B510BD6BB Q57418489-F8A17929-9285-4C2E-A1AE-049E52DFA909

P2860

Skeletal muscle insulin resistance in endocrine disease.

http://www.wikidata.org/entity/Q33734293

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Skeletal muscle insulin resistance in endocrine disease.

@ast

Skeletal muscle insulin resistance in endocrine disease.

@en

type

label

Skeletal muscle insulin resistance in endocrine disease.

@ast

Skeletal muscle insulin resistance in endocrine disease.

@en

prefLabel

Skeletal muscle insulin resistance in endocrine disease.

@ast

Skeletal muscle insulin resistance in endocrine disease.

@en

P1433

Q33734293-1A11A539-4F9B-438D-B675-4E4B5CD77346

P1476

Q33734293-BA878E89-A3AF-4BFE-966D-61491C094DC5

P2093

Q33734293-0373BFCD-A502-4F48-8A80-5C0829A2373C

Q33734293-125128B7-57FC-4A04-8F2E-DEA9C4EFB758

Q33734293-37EC76E9-7776-433C-8D96-5283F2271CC4

Q33734293-E3510A09-80D0-47EE-8317-F7AB24E1FE9A

P2860

Q33734293-0048C206-A980-4A92-BE2F-E4E5ABFDF97F

Q33734293-02497F18-93A5-46B2-B6F6-C331DD43F343

Q33734293-089FBF41-C6D3-4810-A857-10BE8B008095

Q33734293-0DDDE315-6873-42D6-B9C6-CC04A7351067

Q33734293-0E92C3A1-8612-42D7-A090-C3545C497E4F

Q33734293-17D5CB54-8DA4-4B3C-BDEE-DD18F1AE1E2D

Q33734293-19489224-3E64-4952-8CE3-E7CF3140A6A3

Q33734293-1CA3035B-D125-403E-AB57-9707E9CCC530

Q33734293-1CD299B3-23FB-4605-907D-E446528EA36E

Q33734293-204C074A-DD67-4405-9243-7EEE35DA534E

P304

Q33734293-75C7D986-D7AC-4CB4-90A4-83BC3F435241

P31

Q33734293-33D2F41B-BF2D-4237-AAA9-4DA1BA9C7C35

Q33734293-BD6FDA62-AEEA-4388-B1EE-FB1B25ABD3D5

P356

Q33734293-A9EAC852-2081-4D2E-B31D-8780DC9BA53E

P478

Q33734293-2C972B45-82C4-41A8-A012-2CC61AC59275

P577

Q33734293-743450CB-BBF8-4CB2-BC71-6B623E0A91D3

P5875

Q33734293-2D71CD30-232F-4DCF-BEA3-EE855F14CC69

P698

Q33734293-C1111FC5-DB0B-4BA9-9964-A1032541536B

P921

Q33734293-2D738AAD-B391-45A4-93BF-9472F1B28694

Q33734293-2F096005-6F14-422C-B93F-B314CC7F6511

Q33734293-415D82CD-6447-43B3-96BC-6C620EC77CBC

Q33734293-47BC13D2-A44B-4F31-AE1D-F3AFC012E093

Q33734293-4B9BD735-977E-464C-8D9B-0DC2F383023A

Q33734293-655D4000-33A1-42C2-AD9A-242E9232F367

Q33734293-7664DCFD-6019-4FF2-AE5C-0830C4054166

Q33734293-D975B223-83DB-45FE-B213-D1B9BE87AC11

P932

Q33734293-D8F03E48-81D7-48E9-B67A-9AE09E6069C1

P356

P1433

Journal of Biomedicine and Biotechnology

P1476

Skeletal muscle insulin resistance in endocrine disease.

@en

P2093

Chrysi Koliaki

http://www.w3.org/2001/XMLSchema#string

Melpomeni Peppa

http://www.w3.org/2001/XMLSchema#string

Panagiotis Nikolopoulos

http://www.w3.org/2001/XMLSchema#string

Sotirios A Raptis

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin signalling and the regulation of glucose and lipid metabolism

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action

Insulin signaling stimulates insulin transport by bovine aortic endothelial cells.

Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia.

Insulin resistance in polycystic ovary syndrome: progress and paradoxes.

Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.

Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistance

P304

527850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/527850

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42345984

http://www.w3.org/2001/XMLSchema#string

P698

20300436

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

endocrine system disease

physiological phenomena

human musculoskeletal system

P932

2840413

http://www.w3.org/2001/XMLSchema#string